An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

On the latest episode of the science talk show GEN Live, I was joined by a pair of experts to discuss the state of ...

A new bioprocessing technique developed by a team of researchers could improve a range of therapies based on CAR-T cells.

A primary drying process model that includes the various sources of process variability can guide the process optimization ...

Researchers investigated RA51C and uncovered over 3,000 harmful genetic changes that could increase cancer risk.

Cancer cells can use lipids not just as fuel, but as a means to obscure inflammatory signals, enabling immune evasion.

There is no general implemented and fully protective preventative treatment available for Group B Streptococcus.

Filoviruses—such as Ebola and Marburg viruses—can cause hemorrhagic fevers with up to 90% lethality. Not only that, but there ...

CDMOs are willing to invest in innovative bioprocessing technologies, but the economics need to make sense. Platforms that ...

An international collaboration of researchers in Europe and the U.S. has identified a critical immune factor for host defense against Staphylococcus aureus, which could offer a potential explanation ...

DFI therapy cost the UK’s NHS up to £962 million ($1.27 billion) each year. In the U.S., amputation cost alone is $1.38 ...